Leon F. Tseng

Leon F. Tseng

Auto-generated profile, based on publicly available information

Leon F. Tseng

Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2000 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
LTLeon F. Tseng
Leon F. Tseng
MNMinoru Narita
Minoru Narita
CSChiaki Suganuma
Chiaki Suganuma
HMHirokazu Mizoguchi
Hirokazu Mizoguchi
MOMasahiro Ohsawa
Masahiro Ohsawa
JKJohn P. Kampine
John P. Kampine

1 December 2001 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
LTLeon F Tseng
Leon F Tseng


13 November 2006 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
HWHsiang‐En Wu
Hsiang‐En Wu
HSHan‐Sen Sun
Han‐Sen Sun
CCCaleb W. Cheng
Caleb W. Cheng
MTMaia Terashvili
Maia Terashvili
LTLeon F. Tseng
Leon F. Tseng

1 January 2002 in The Japanese Journal of Pharmacology
Verified
Journal Article
Open access
LTLeon F. Tseng
Leon F. Tseng
Two highly selective mu-opioid receptor agonists, endomorphin-1 (EM-1) and endomorphin-2 (EM-2), have been identified and postulated to be endogenous mu-opioid receptor ligands. The present minireview describes the antinociceptive properties with the tail-flick test of these two ligands given intracerebroventricularly (i.c.v.) and intrathecally (i.t.) in ICR mice. EM-1 or EM-2 given i.c.v. or i.t. dose-dependently produce antinociception. These antinociceptive effects induced by EM-1 and EM-2 given i.c.v. or i.t. are selectively mediated by the stimulation of mu-, but not delta- or kappa-opioid receptors. Like other mu-opioid agonists morphine and DAMGO ([D-Ala2,NMePhe4,Gly5-ol]enkephalin), EM-1 and EM-2 given i.c.v. activate descending pain controls by the releases of noradrenaline and 5-HT and subsequently act on alpha2-adrenoceptors and 5-HT receptors, respectively, in the spinal cord to produce antinociception. However, the antinociception induced by EM-2 given i.c.v. or i.t. also contain an additional component, which is mediated by the release of dynorphin A(1-17) acting on kappa-opioid receptors at the supraspinal and spinal sites. In addition, the antinociception induced by EM-2 given i.c.v. contains another component, which is mediated by the release of Met-enkephalin acting on delta2-opioid receptors in the spinal cord. It is proposed that there are two subtypes of mu-opioid receptors,which are involved in EM-1- and EM-2-induced antinociception. One subtype of mu-opioid receptors is stimulated by EM-1, EM-2 and other mu-opioid agonists morphine and DAMGO; and another subtype of mu-opioid is sorely stimulated by EM-2 and is involved in the releases of dynorphin A(1-17) and Met-enkephalin for the production of antinociception.

9 November 2002 in Neuroscience
Verified
Journal Article
Closed access
HMH Mizoguchi
H Mizoguchi
HWH.-E Wu
H.-E Wu
MNM Narita
M Narita
Frank Scott HallFrank Scott Hall
Frank Scott Hall
ISI Sora
I Sora
LTL.F Tseng
L.F Tseng